This slide show highlights some of the most read stories on Cancer Network in 2016, including guidelines on surgical margins in DCIS, a study on serum vitamin D levels in breast cancer patients, and more.
In this slide show we highlight some of the top news on sarcoma in 2016, including the first frontline FDA approval in 40 years, and studies on imaging in Ewing sarcoma, maintenance chemotherapy in osteosarcoma, and more.
This slide show highlights 2016 FDA approvals of cancer treatments, which to date include therapies for RCC, neuroendocrine tumors, Hodgkin lymphoma, CLL, sarcoma, bladder cancer, lung cancer, and breast cancer.
In this slide show we highlight some of the top news on lung cancer in 2016, including an immunotherapy approval from the FDA, and studies on depression in lung cancer patients, serious side effects to watch for when using immunotherapies, and more.
This slide show highlights some of the top news of 2016 on hematologic malignancies, including FDA approvals for myeloma, lymphoma, and leukemia, and studies on transplantation, risk of recurrence in AML patients, and more.
This slide show highlights some of the top prostate cancer news of 2016, including studies on aspirin use and cancer risk, the increased incidence of colorectal tumors in prostate cancer patients, hormone therapy and a link to depression, and more.
Although melanoma represents less than 5% of skin cancers, it results in the most deaths. In the United States this year an estimated 76,380 new cases of melanoma will be diagnosed, and 10,130 people will die of the disease. Test your knowledge of melanoma risk factors, diagnosis, and treatment in our latest quiz.
Do you know the ASCO guidelines for metastatic castration-resistant prostate cancer? How about prostate cancer incidence in various countries? Test your knowledge on these topics and more in our latest quiz.